SINGAPORE (Feb 14): CIMB is leaving its DPU estimates of RHT Health Trust unchanged and maintaining its "hold" call with 92 cents target price pending further details on the transaction in the upcoming circular.
Following an initial announcement in Nov 2017, RHT announced on Monday it had entered into a master purchase agreement with Fortis Healthcare in relation to the disposal of the entire asset portfolio of RHT Health Trust.
This includes its interests in 12 clinical establishments, four greenfield clinical establishment and two operating hospitals in India, to Fortis. The deal is subject to unitholders’ approval at an EGM. The long stop date is Sept 30.